Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Exogenous Ketosis (IEK): A Novel Strategy to Improve Hypoxic Tolerance and Adaptation

NCT06097754 is registered in ClinicalTrials.gov with Jozef Stefan Institute as lead sponsor.

NCT NCT06097754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06097754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Exogenous Ketosis (IEK): A Novel Strategy to Improve Hypoxic Tolerance and Adaptation
Lead sponsor
Jozef Stefan Institute
Phase
Not applicable
Overall status
Unknown status
Start date
September 18, 2023
Completion date
June 30, 2024
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxia, ketosis